Log In
BCIQ
Print this Print this
 

ASP5633

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionUndisclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationIncontinence
Indication DetailsTreat stress urinary incontinence (SUI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today